Lichen Sclerosus and PRP: What an Orlando Physician Wants You to Know

Lichen sclerosus is one of the most underdiagnosed and under-discussed chronic conditions affecting women’s health. It’s also one where I’ve seen some of the most meaningful patient outcomes from PRP therapy outcomes backed by genuinely compelling published research.

If you or someone you know has been diagnosed with lichen sclerosus, or if you’re experiencing symptoms and haven’t yet received a diagnosis, I want you to understand what this condition is, what conventional treatment looks like, and why PRP has become a topic worth taking seriously.

What Is Lichen Sclerosus?

Lichen sclerosus (LS) is a chronic inflammatory skin condition that most commonly affects the vulva and perianal region in women. It causes the affected tissue to become white, thin, and fragile a process called sclerosis. Symptoms typically include:

• Intense itching, especially at night
• Burning or stinging discomfort
• White, patchy, or crinkled skin appearance
• Pain during intercourse (dyspareunia)
• Skin tearing, cracking, or bleeding with minimal friction
• In advanced cases: architectural changes including fusion of labial tissues or clitoral scarring

The exact cause of lichen sclerosus is not fully understood. Autoimmune mechanisms, hormonal factors (estrogen deficiency plays a role in many postmenopausal cases), and genetic predisposition all appear to contribute. It is not contagious and is not caused by poor hygiene.

Lichen sclerosus can affect women of any age, but it is most commonly diagnosed in postmenopausal women and interestingly in pre-pubertal girls, though the two age groups have different presentations and some differences in management.

Conventional Treatment Options

The standard of care for lichen sclerosus has historically been topical corticosteroids typically clobetasol propionate (a potent steroid) applied to the affected tissue. For many patients, this reduces itching and inflammation and slows architectural changes. It is an ongoing treatment, not a cure: most patients require long-term maintenance application.

Limitations of topical steroid treatment include: skin thinning with prolonged use, incomplete response in some patients, patient discomfort with chronic steroid application to sensitive tissue, and importantly limited ability to reverse architectural changes that have already occurred.

For patients who do not respond adequately to topical steroids, options have historically been limited: other immunomodulatory creams, surgery to address fused or scarred tissue, and in some cases low-dose topical estrogen (particularly postmenopausal patients).

Why PRP Is Being Studied for Lichen Sclerosus

Lichen sclerosus involves both inflammatory damage and tissue structural change. PRP platelet-rich plasma containing concentrated growth factors works on both fronts. Growth factors in PRP (PDGF, VEGF, TGF-β, IGF-1 and others) have anti-inflammatory properties, stimulate collagen remodeling, and support tissue regeneration.

The hypothesis, now backed by published research: PRP injections into lichen sclerosus-affected tissue can reduce the inflammatory burden, support tissue architecture restoration, and improve quality of life beyond what topical steroids alone can achieve.

What the Research Shows

Boero et al. 2024 100% Patient Satisfaction

A 2024 study (PMID: 39804749) examined PRP treatment for vulvar lichen sclerosus and reported 100% patient satisfaction, alongside significant reductions in symptom scores. Itching, burning, and dyspareunia all showed measurable improvement. This is notable in a condition where patients often cycle through treatments with inconsistent relief.

Self-Controlled Pilot Study FSFI and Quality of Life Gains

A 2024 self-controlled pilot study (PMID: 38523203) measured outcomes in lichen sclerosus patients treated with PRP using validated instruments including the Female Sexual Function Index (FSFI), the Hospital Anxiety and Depression Scale (HADS), and the Short Form-12 quality-of-life survey. Significant improvements were found across sexual function, psychological wellbeing, and overall quality of life.

The use of validated, standardized measures rather than informal patient reports matters here. These are tools used across reproductive medicine research, which allows for comparison with other published literature.

Dr. J’s Approach to Lichen Sclerosus

I trained in internal medicine and have practiced for over 25 years. Lichen sclerosus sits at the intersection of dermatology, gynecology, and autoimmune medicine and honestly, it doesn’t always receive the multidisciplinary attention it deserves. Patients sometimes go years with misdiagnosed or undertreated symptoms.

At Dr. J Anti-Aging Clinic, I approach lichen sclerosus comprehensively. If you haven’t received a formal diagnosis from a dermatologist or gynecologist, I will refer you for confirmation before proceeding with PRP treatment that biopsy or clinical evaluation matters. If you’ve been diagnosed and are on topical steroids but experiencing incomplete relief or progressive changes, PRP is worth a serious conversation.

I also look at the full hormonal picture. Many lichen sclerosus patients especially postmenopausal women also have estrogen deficiency contributing to tissue vulnerability. In those cases, addressing both the inflammatory process and the hormonal environment often produces better outcomes than either intervention alone.

What PRP Treatment for Lichen Sclerosus Looks Like at Dr. J Anti-Aging Clinic

The procedure is the same as our standard O-Shot / FemiFresh Shot protocol: blood draw, PRP preparation, topical numbing, injection into affected tissue. For LS patients, we map injection placement to the areas of most significant involvement.

Session count varies by case. Some patients see meaningful improvement after a single treatment. For patients with more significant tissue involvement, we typically recommend a series of 2 to 3 sessions over 3 to 6 months, then reassess.

Frequently Asked Questions

Can PRP replace my topical steroid treatment for lichen sclerosus?

Not necessarily and I would be cautious about stopping steroid treatment without dermatologic or gynecologic guidance. Many LS patients continue topical steroid maintenance alongside PRP therapy. The goal of PRP is to add a regenerative layer to treatment, not simply swap one approach for another.

How do I know if I have lichen sclerosus?

Diagnosis is typically made by a dermatologist or gynecologist through clinical examination and often a small biopsy of the affected tissue. If you’re experiencing unexplained vulvar itching, burning, white or thin patches, or pain with intercourse, please seek a formal evaluation. At Dr. J Anti-Aging Clinic, I can review your history and refer you for evaluation if needed.

Can younger women develop lichen sclerosus?

Yes. While LS is most commonly diagnosed in postmenopausal women, it affects women across the age spectrum including reproductive-age women and, in a distinct presentation pattern, pre-pubertal girls. Treatment considerations differ somewhat by age and hormonal status.

Is PRP for lichen sclerosus covered by insurance?

PRP injection therapy is currently considered elective and is not typically covered by insurance plans for lichen sclerosus. Please contact our office for current pricing and to discuss package options.

Dr. J Anti-Aging Clinic by Dr. J serves women in Dr. Phillips, Orlando, Winter Park, Kissimmee, Lake Nona, Altamonte Springs, Clermont, Windermere, Sanford, Lakeland, Melbourne, and throughout Central Florida.